Concordance between high antibiotic prescribing and high opioid prescribing among primary care physicians: a cross-sectional study.
Journal
CMAJ open
ISSN: 2291-0026
Titre abrégé: CMAJ Open
Pays: Canada
ID NLM: 101620603
Informations de publication
Date de publication:
Historique:
entrez:
10
3
2021
pubmed:
11
3
2021
medline:
20
7
2021
Statut:
epublish
Résumé
Antimicrobial resistance and opioid misuse both present major public health challenges, and identifying high prescribers of both of these agents can help provide a common target for intervention. We sought to determine the association between being a high prescriber of antibiotics and being a high prescriber of opioids in the primary care setting. We performed a cross-sectional study of the antibiotic- and opioid-prescribing habits of primary care physicians in Ontario, Canada between Mar. 1, 2017, and Feb. 28, 2018, using administrative databases. We defined high prescribers as the top quartile of antibiotic or opioid prescribers using 3 antibiotic-prescribing metrics (prescriptions per patient visit, proportion of prescriptions that were broad spectrum and proportion of prescriptions > 8 d) and 3 opioid-prescribing metrics (prescriptions per patients seen, proportion of prescriptions > 90 mg of morphine equivalents and proportion of prescriptions > 28 d). We tabulated agreement between prescribing metrics using the κ statistic. We included 9994 physicians. We observed minimal overlap between high antibiotic initiation and high opioid initiation (618 physicians [6.2%]) (κ = 0.00, 95% confidence interval -0.02 to 0.02). There was slight agreement between the antibiotic-prescribing indices and between the opioid-prescribing indices (within-class, range of κ 0.05 to 0.18). There was slight disagreement to slight agreement across antibiotic- and opioid-prescribing metrics (between-class, range of κ -0.09 to 0.16). Among primary care physicians, there was a lack of association between high antibiotic prescribing and high opioid prescribing. Our findings suggest that separate tailored approaches to antibiotic and opioid stewardship strategies are needed.
Sections du résumé
BACKGROUND
Antimicrobial resistance and opioid misuse both present major public health challenges, and identifying high prescribers of both of these agents can help provide a common target for intervention. We sought to determine the association between being a high prescriber of antibiotics and being a high prescriber of opioids in the primary care setting.
METHODS
We performed a cross-sectional study of the antibiotic- and opioid-prescribing habits of primary care physicians in Ontario, Canada between Mar. 1, 2017, and Feb. 28, 2018, using administrative databases. We defined high prescribers as the top quartile of antibiotic or opioid prescribers using 3 antibiotic-prescribing metrics (prescriptions per patient visit, proportion of prescriptions that were broad spectrum and proportion of prescriptions > 8 d) and 3 opioid-prescribing metrics (prescriptions per patients seen, proportion of prescriptions > 90 mg of morphine equivalents and proportion of prescriptions > 28 d). We tabulated agreement between prescribing metrics using the κ statistic.
RESULTS
We included 9994 physicians. We observed minimal overlap between high antibiotic initiation and high opioid initiation (618 physicians [6.2%]) (κ = 0.00, 95% confidence interval -0.02 to 0.02). There was slight agreement between the antibiotic-prescribing indices and between the opioid-prescribing indices (within-class, range of κ 0.05 to 0.18). There was slight disagreement to slight agreement across antibiotic- and opioid-prescribing metrics (between-class, range of κ -0.09 to 0.16).
INTERPRETATION
Among primary care physicians, there was a lack of association between high antibiotic prescribing and high opioid prescribing. Our findings suggest that separate tailored approaches to antibiotic and opioid stewardship strategies are needed.
Identifiants
pubmed: 33688025
pii: 9/1/E175
doi: 10.9778/cmajo.20200122
pmc: PMC8034295
doi:
Substances chimiques
Analgesics, Opioid
0
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
E175-E180Informations de copyright
© 2021 Joule Inc. or its licensors.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
JAMA Intern Med. 2013 Apr 22;173(8):673-82
pubmed: 23552741
Biochem Med (Zagreb). 2012;22(3):276-82
pubmed: 23092060
Antimicrob Agents Chemother. 2013 May;57(5):2326-32
pubmed: 23478961
Can Fam Physician. 2011 Mar;57(3):e92-6
pubmed: 21402956
MMWR Morb Mortal Wkly Rep. 2018 Jan 04;67(5152):1419-1427
pubmed: 30605448
J Antimicrob Chemother. 2011 Dec;66(12):2856-63
pubmed: 21954456
CMAJ. 2017 Jun 26;189(25):E851-E860
pubmed: 28652480
MMWR Morb Mortal Wkly Rep. 2017 Mar 17;66(10):265-269
pubmed: 28301454
Lancet. 2016 Apr 23;387(10029):1743-52
pubmed: 26898856
J Gen Intern Med. 2019 Dec;34(12):2763-2771
pubmed: 31576508
JAMA. 2003 Feb 12;289(6):719-25
pubmed: 12585950
JAMA Intern Med. 2016 Sep 1;176(9):1254-5
pubmed: 27455385
JAMA. 2016 Apr 19;315(15):1624-45
pubmed: 26977696
JAMA Intern Med. 2015 Aug;175(8):1331-9
pubmed: 26121537
J Antimicrob Chemother. 2019 Jul 1;74(7):2098-2105
pubmed: 31002333
J Clin Pharm Ther. 2020 Oct;45(5):892-903
pubmed: 31986228
PLoS One. 2019 Sep 26;14(9):e0223097
pubmed: 31557249
Clin Infect Dis. 2020 Aug 12;:
pubmed: 32785696
CMAJ. 2017 May 8;189(18):E659-E666
pubmed: 28483845
Br J Gen Pract. 2019 Jan;69(678):e42-e51
pubmed: 30559110
BMJ. 2018 Aug 29;362:k3207
pubmed: 30158106